X
skip to main content
Logo
media conference

Press Releases

  • August 03, 2018

    To register a team for the Terry Fox Run 2018, please visit http://www.terryfox.org/run/teams/, or join our TFRI Headquarters team captained by Dr. Victor Ling.

  • August 02, 2018

    Over the past year, the Terry Fox Canadian Comprehensive Cancer Centre Network (TF4CN) has fostered unprecedented collaborations, harmonized complex research methods and created the basic framework for a digital platform that allows patient data to be shared, stored and analyzed.

  • July 11, 2018

    An international team of leukemia scientists that includes TFRI-funded researchers has discovered how to predict healthy individuals at risk of developing acute myeloid leukemia (AML), an aggressive and often deadly blood cancer.

  • June 28, 2018

    Seeking to improve treatments for 18,000 annual cancer patients, leading researchers, cancer centres and hospitals in Montreal and The Terry Fox Research Institute have partnered to generate new advances in personalized and precision medicine.

  • June 12, 2018

    Dr. Victor Ling is among several prominent Chinese Canadians featured in a newly published 180-page, full-colour book titled Celebration: Chinese Canadian Legacies in British Columbia.

  • June 12, 2018

    Three outstanding cancer research teams will receive nearly $13 million to continue their investigations into rare tumours, an inherited disorder (Li-Fraumeni Syndrome) and the use of magnetic resonance imaging (MRI) and ultrasound to improve treatments for breast cancer.

  • May 17, 2018

    A new study led by Dr. Rebecca Auer, a member of TFRI's Oncolytic Virus project and former recipient of a TFRI New Investigator Award, suggests that a common treatment for erectile dysfunction combined with the flu vaccine may be able to help the immune system mop up cancer cells left behind after surgery.

  • May 15, 2018

    Metastatic castration-resistant prostate cancer (mCRPC) patients are now one step closer to more personalized treatment, thanks to a new test that can distinguish who will respond well to standard therapies and who will become resistant to treatment.

  • May 15, 2018

    Findings from a recent study published in Cell are breaking new ground in the pediatric brain cancer world, suggesting medulloblastoma cells can metastasize in an entirely different way than previously assumed.

  • May 15, 2018

    A cancer research team funded partly by The Terry Fox Research Institute has identified the best method for sequencing gene mutations across several of the most common forms of lymphoid cancer.

  • May 15, 2018

    Targeting hypoxia can, in turn, target cancer-initiating cells (C-ICs) in colorectal cancer a study team in Toronto has found. Additionally, the team has discovered a biomarker for hypoxia to identify tumours that would most benefit from this innovative treatment method.

  • May 15, 2018

    A collaboration between Swiss and Canadian research institutes has shown an effective way to enhance human hematopoietic stem and progenitor cell engraftment after stem cell transplantation by blocking donor T cell-mediated TNFα signalling.

  • May 14, 2018

    The Terry Fox Research Institute (TFRI) is seeking applications for two of its prestigious grant programs: The Terry Fox New Frontiers Program and the Terry Fox New Investigators Awards.

  • May 10, 2018

    A new study led by a team of TFRI-funded researchers has uncovered the mechanisms through which deadly ovarian cancer cells escape the immune system, setting the stage for a better understanding of how and why patients respond to promising new immunotherapies.

  • May 01, 2018

    More findings from TFRI’s prestigious hypoxia team are continuing to change the cancer research landscape when it comes to understanding the role of the mTOR signalling pathway in the development and aggressiveness of prostate cancer.

Back to Top